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ABSTRACT
￿
The effect of p-nitrophenyl-ß-D-xylopyranoside on glomerular extracellular mat-
rices (glomerular basement membrane and mesangial matrix) proteoglycans was studied. The
proteoglycans of rat kidneys were labeled with ["SJsulfate in the presence or absence of ß-
xyloside (2 .5 mM) by using an isolated organ perfusion system. The proteoglycans from the
glomeruli and perfusion medium were isolated and characterized by Sepharose CL-6B chro-
matography and by their behavior in CsCl density gradients. With xyloside treatment there
was a twofold decrease in "S-labeled macromolecules in the tissues but a twofold increase in
those recovered in the medium as compared with the control . The labeled proteoglycans
extracted from control kidneys eluted as a single peak with Kav = 0.25 (Mr =
￿
130,000), and
-95% of the radioactivity was associated with heparan sulfate proteoglycan (HS-PG), there-
mainder with chondroitin (or dermatan) sulfate proteoglycan (CS-PG). In the xyloside-treated
kidneys, the proteoglycans extracted from the tissue eluted as two peaks, K"Y = 0.25 (Mr =
130,000) and 0.41 (Mr =
￿
46,000), which contained -40 and -60% of the total radioactivity,
rspectively. The first peak contained mostly the HS-PG (-90%) while the second peak had a
mixture of HS-PG (-70%) and CS-PG (-30%) . In controls, -90% of the radioactivity, mostly
HS-PG, was confined to high density fractions of a CsCl density gradient. In contrast, in
xyloside experiments, both HS-PG and CS-PG were distributed in variable proportions
throughout the gradient. The incorporated 35S activity in the medium of xyloside-treated
kidneys was twice that of the controls and, had three to four times the amount of free
chondroitin (or dermatan) sulfate glycosaminglycan chains. The data suggest that ß-xyloside
inhibits the addition of de novo synthesized glycosaminoglycan chains onto the core protein
of proteoglycans and at the same time stimulates the synthesis of chondroitin or dermatan
sulfate chains which are mainly discharged into the perfusion medium .
Glomerular extracellular matrices (GEMs)' contain a network
of anionic sites (1, 10, 30) which are largely made up of
heparan sulfate (11, 12) and small amounts of chondroitin
sulfate glycosaminoglycans (GAGS) (13, 23). Glomerular
basement membranes (GBMs) contain predominantly hepa-
ran sulfate, while chondroitin sulfate is enriched in the mes-
angial matrix of GEMS (14, 17). Heparan sulfate GAGS of
'Abbreviations used in this paper:
￿
CS-PG, chondroitin sulfate pro-
teoglycan; GAG, glycosaminoglycan; GBM, glomerular basement
membranes; GEM, glomerular extracellular matrix; HS-PG, heparan
sulfate proteoglycan.
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GEMS are covalently bound by O-glycosidic linkage to the
core (13, 19) protein via galactosyl-galactosyl-xylosyl-serine.
GAG chains are added onto the core protein stepwise and are
initiated by UDP-D-xylose:core protein xylosyltransferase fol-
lowed by other transferases for completion of these chains (5,
6,33).
In cultures of cartilage and other tissues, it has been shown
that D-xylose or ß-xylosides added to the medium stimulates
the synthesis of free GAG chains by acting as an initiator of
chain formation, thus bypassing the requirement for the core
protein and the xylosyl transferase (24, 29, 31, 37). The
xyloside-initiated chains are not retained in the extracellular
715matrices and are discharged rapidly into the medium. At the
same time, the net synthesis of chondroitin sulfate on the core
protein is inhibited. The studies so far reported concerning
xylosides pertain primarily to the synthesis of proteoglycans
in cartilage (26, 36, 37), chick limb bud mesenchymal cell
cultures (25), embryonic salivary glands (43, 44), mast cells
(32, 39, 40), bone marrow-derived cells (38), 3T3 cells (7),
hepatocytes (42), or murine embryonal carcinoma cell lines
(22). Data concerning the synthesis of heparan sulfate proteo-
glycan of native mammalian basement membranes in the
presence of xylosides is limited. The purpose of the present
study was to investigate the effect of ß-D-xyloside on the de
novo synthesized proteoglycans of GEMS.
MATERIALS AND METHODS
Materials:
￿
Male Charles River CD® rats weighing 300-350 g were used
in these experiments. Sepharose CL-6B, Sephadex G-50, and DEAE-Sephacel
were purchased from Pharmacia Fine Chemicals (Piscataway, NJ); p-nitro-
phenyl-ß-o-xylopyranoside from Research Product International Corp. (Elk
Grove, IL); chondroitinase-ABC from Miles Laboratories, Inc. (Elkhart, IN);
['H]serine (15 Ci/mmol) and ["S]sulfate (-900 Ci/mmol) from Amersham
Corp. (Arlington Hts., IL). ['H]Serine-labeled cartilage proteoglycan monomer
(20) was a gift of Dr. James H. Kimura (Rush Medical College, Chicago, IL).
Radiolabeling of Glomerular Proteoglycans:
￿
Radiolabeling of
glomerular proteoglycans was carried out in an ex situ organ perfusion appa-
ratus (l7). The ex situ organ perfusion technique is much more effective in
labeling the proteoglycans than are isolated glomerular culture systems; in the
latter the viability ofthe various cell types ofthe glomerulus has been seriously
questioned (28). Furthermore, the ex situ organ perfusion technique almost
mimics in vivo conditions while obviating many ofthe problems encountered
when labeling in vivo, including: (a) the rapid clearance of sulfate from blood,
thereby making maintenance ofconstant levels of ["S]sulfate difficult, and (b)
the presence ofhigh levels of inorganic sulfate in the plasma (0.6 mg/dl) which
competitively reduces the uptake of ["S]sulfate by the kidney.
The entire ex situ organ perfusion procedure was carried out under sterile
conditions. Animals were anesthetized by injection of inactin (10 mg/100 g
body wt). The right kidney was isolated, and its renal artery was cannulated
and flushed with oxygenated Krebs-Ringer bicarbonate, pH 7.4. The cannulated
kidney was removed from the animal and attached to a recirculating ex situ
perfusion system. The perfusate consisted of modified Krebs-Ringer bicarbon-
ate containing 7.5% BSA, basal medium Eagle amino acid (5 ml ofamino acid
solution/100 ml of perfusate), insulin (240 kIU/ml), glucose (1 .8 mg/ml),
["S]sulfate (100 yCi/ml), and inorganic sulfate (30 UM). The kidneys were
perfused at 8-10 ml/min and labeled for 1, 2, 3, and 4 h under normothermic
and well-oxygenated conditions. Subsequently, the kidneys were perfused with
a chase medium similar to the labeling perfusate, but lacking ["S]sulfate and
containing 3.0 mM of inorganic sulfate. For the xyloside experiments, 2.5 mM
ofp-nitrophenyl-ß-D-xylopyranoside was included in the perfusate. Four kid-
neys were used for each time point per variable. A small biopsy was taken from
the kidneys from the last time point (4 h) and processed for electron microscopy
in order to ascertain any cytotoxic effect of the xyloside on the tissues. At the
end ofthe labeling period, the perfusate was saved for isolation and character-
ization of proteoglycans and free GAG chains in the medium.
Isolation of Glomeruli and Extraction of Proteoglycans:
Radiolabeled kidneys were perfused with Krebs-Ringer bicarbonate containing
1 % BSA and protease inhibitors (1 mM of phenylmethylsulfonyl fluoride and
diisopropyl fluorophosphate), pH 7.0. The kidneys were bisected and cortices
weredissected free and frozen at -20°C. After 12-24 h, the cortices were thawed
at 4°C and glomeruli were isolated by the sieving technique (21). The proteo-
glycans were extracted from isolated glomeruli with 4 M guanidine-HCI con-
taining 0.01 M sodium EDTA, 0.01 M sodium acetate, pH 5.8, and a mixture
of protease inhibitors (0.1 M 6-aminohexanoic acid, 0.005 M benzamidine-
HCI, and 0.001 M phenylmethylsulfonyl fluoride; references 13 and 19). The
extraction was carried out for 48 h at 4°C with continuous stirring. The
unextracted residue was pelleted by centrifugation at 10,000 rpm in a Beckman
microfuge (Beckman Instruments Inc., Palo Alto, CA). The residue was ex-
tracted with 0.5 N NaOH at 60°C for 3 h to solubilize remaining GAGS. The
extracts were dialyzed against distilled watercontaining 1 mM of phenylmeth-
ylsulfonyl fluoride and diisopropyl fluorophosphate at 4°C. Aliquots from both
the guanidine-HCI and the NaOH extracts were saved for monitoring radioac-
tivities. Aliquots from the guanidine-HCI extracts were assayed for protein
content (27). The remaining sampleswere frozen and lyophilized before further
characterization.
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Characterization of Extracted Glomerular Proteoglycans:
Samples from untreated and xyloside-treated kidneys were eluted under disso-
ciative conditions on a Sepharose CL-6B column (100 x 0.9 cm). Each sample
was reconstituted with 100-200 Kl of 4 M guanidine-HCI before chromato-
graphic analysis. The column was eluted with 4 M guanidine-HCI, 100 mM
Tris-HCI, 0.1 M sodium sulfate, 0.5% (vol/vol) Triton X-100, pH 7.0, ata flow
rate of--2.4 ml/h, and fractions of --0.6 ml were collected. We determined the
void (V) and total (V,) volumes of columns by eluting ["S]serine-labeled
cartilage monomer proteoglycan (for V) and ['H]serine (for V,) with the same
buffer. The radioactivity in each of the effluent fractions was determined in a
Beckman LS-9000 scintillation counter.
Aliquots of intact glomerular proteoglycans were treated either with chon-
droitinase-ABC (0.25 U/ml) after reconstitution in 0.5 ml of 0.1 M Na acetate,
0.1 M Tris-HCI buffer, pH 7.3, for 2 h at 37°C (35) or with nitrous acid
(prepared by mixing equal volumes of 20% [wt/vol] butyl nitrite and l N HCI)
for 4 h at room temperature (3). After the treatments, the samples were
lyophilizedto dryness and reconstituted with 4 M guanidine-HCI. Degraded as
well as undegraded samples were chromatographed on Sepharose CL-6B. The
molecular weights ofglomerular proteoglycans from xyloside-treated and con-
trol kidneys were estimated by interpolation of K,, values for peak elution
positions with the data obtained from sized tryptic-chymotryptic fragments of
cartilage proteoglycan (4).
Some of the lyophilized aliquots ofthe extracted proteoglycans were pooled,
reconstituted with 4 M guanidine-HCI, adjusted to an initial density of 1 .42 g/
ml by addition of0.45 g ofCsCl/g solution, and centrifuged at 35,000 rpm in
a SW Ti 55 rotor for 72 h at 10°C (13, 19). Five equal fractions, D, to D, from
bottom to top, were collected. The density of each fraction was determined
with a Bausch & Lomb Abbe-3L refractometer (Bausch & Lomb Inc., Roch-
ester, NY). An aliquot of each of the fractions was saved for monitoring
radioactivity, and the remainder was chromatographed before and after treat-
ment with chondroitinase-ABC or with nitrous acid, as described above.
Characterization of Glomerular GAGS: Extracted glomerular
proteoglycans from xyloside-treated and control kidneys were treated with 0.5
N NaOH at 60°C for 3 h in order to liberate the GAG chains. The hydrolyzates
were dialyzed against distilled water, lyophilized, and chromatographed on
Sepharose CL-6B before and after treatment with nitrous acid. The molecular
weights of the chains were estimated by comparison of peak elution positions
with values obtained by Wasteson for chondroitin sulfate (45). Portions were
also reconstituted with 4 M guanidine-HCI and subjected to CsCI density
gradient centrifugation as described above. D, to D, fractions were collected
and a small aliquot of each fraction was used for monitoring radioactivity. The
D, fractions from the xyloside and control experiments were chromatographed
on Sepharose CL-6B before and after treatment with chondroitinase-ABC or
nitrous acid.
In xyloside experiments, the effluent fractions from Sepharose CL-6B cor-
responding to elution peaks of intact proteoglycans (peak 1, fractions 35-45,
with K., = 0.25; and peak 2, fractions 46-56, with K. = 0.41 ; see Fig. 3) were
recovered. The peaks were separately pooled, dialyzed against distilled water,
and lyophilized. Samples were then treated with 0.5 N NaOH at 60°C for 3 h,
redialyzed against distilled water, lyophilized, and chromatographed before and
after treatment with chondroitinase-ABC or nitrous acid.
Isolation and Purification of Proteoglycans and GAGS from
the Perfusion Medium:
￿
Disposable columns of Sephadex G-50 (fine)
were prepared in plastic serological pipettes to give a 10-ml bed volume. The
gels were equilibrated with 8 M urea, 0.15 M NaCI, 0.05 M sodium acetate,
pH 6.0, and 0.5% (vol/vol) Triton X-100 (2). Aliquots of 1 .0 ml from the
perfusion media (xyloside and control) were applied to the individual columns
and eluted with the same solution. The excluded fractions were collected,
dialyzed against distilled water, lyophilized, and reconstituted to l ml with 0.1
M NaCl.
The reconstituted fractions were then applied to a 5.0-ml column ofDEAE-
Sephacel equilibrated with 0.1 M NaCl. After loading, columns were washed
with 10 ml of 0.1 M NaCl followed by elution with a continuous 0.1-1.0 M
gradient using a total volume of40 ml. Fractions of 1 .0 ml were collected at a
flow rate of 4.0 ml/h, and aliquots (100 ul) were counted for radioactivity.
Characterization of Medium Proteoglycans and GAGS:
￿
The
fractions with incorporated radioactivity obtained from DEAE-Sephacel chro-
matography werepooled,dialyzed againstdistilled water at 4°C,and lyophilized.
Characterization of these samples was done as described above for the glomer-
ular proteoglycans.
RESULTS
Morphological Features
After 4 h of perfusion, the overall architecture of the
glomeruli was well preserved. In preliminary experiments, theeffect of xyloside concentrations (from 1-5 mM) on the
glomeruli was tested . At concentrations up to 2.5 mM in the
perfusion medium, no deterioration in the glomerular mor-
phology was observed (compare Fig. 1 B with 1 A) . The epi-
thelial and endothelial cells remained adherent to the base-
ment membranes . The mesangial cells did not show any
cytopathic effects. At 5 mM concentration of xyloside in the
medium, mild swelling of the Golgi complexes was observed .
Therefore, subsequent experiments were carried out with 2.5
mM xyloside in the perfusate .
Extraction of Proteoglycans
The efficiency of extraction of radiolabeled proteoglycan
FIGURE 1
￿
Portions of glomerular capillaries from kidneys of control
(A) and xyloside (8) experiments . No discernible changes in the
epithelial (Ep), endothelial (En), and mesangial (Me) cells are ob-
served in the xyloside-treated kidney (2.5 mM, 4 h) as compared
with the control . U5, urinary space ; Cap, capillary lumen . x 9,000.
from whole glomeruli was -96% . In controls, under the
present experimental conditions, the [35S]sulfate incorpora-
tion was -0.85 x 106 dpm/kidney per 4 h . Under identical
labeling conditions, in the presence of2.5 mM ß-xyloside, the
[' SS]sulfate incorporation decreased substantially to -0.2 x
106 dpm/kidney per 4 h (Table I) . The 35S incorporation into
the glomerularProteoglycans in both the control and xyloside-
treated kidneys remained linear up to 4 h (Fig. 2) . The
incorporated radioactivity normalized against micrograms of
glomerular protein from four kidneys per time point was two
to three times less in xyloside-treated kidneys than in the
control (Fig. 2) .
Characterization of Extracted
Glomerular Proteoglycans
The Proteoglycans extracted from glomeruli of control kid-
neys eluted on Sepharose CL-6B as a single peak of radioac-
tivity with a K,. value of0.25 (Fig. 3A) . This value is similar
to that obtained for labeled Proteoglycans isolated from pu-
rified basement membranes prepared from similarly perfused
kidneys which have M, in the range of 130-150,000 . After
nitrous acid oxidation to degrade N-sulfated heparan sulfate,
-95% of the radioactivity was released from the proteoglycan
peak into the V fraction, while after chondroitinase-ABC
digestion to degrade chondroitin 4,6 sulfate and dermatan
sulfate, only -5% ofthe radioactivity was recovered in the V
fraction (Fig . 3A) . The positions ofthe elution peaks resistant
to the above treatments remained unchanged .
The glomerular Proteoglycans extracted from xyloside-
treated kidneys when chromatographed on Sepharose CL-6B
eluted as two peaks (peaks 1 and 2) of radioactivity with K,
values of 0.25 and 0.41 indicating that in addition to the high
molecular weight proteoglycan (peak 1), a smaller molecular
weight proteoglycan with lowerK value (0.41,M r= 46,000 ;
peak 2) (45) was present in the extract (Fig . 3B) . Approxi-
Peaks 1 and 2 are from Fig. 3; peaks A and B are from Fig .8 .
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TABLE I
Totaland Percent Radioactivity in Glomerular and Medium
Fractions
HOURS OF PERFUSION
short half-life of the radioisotope .
FIGURE 2 Incorporation of
["S]sulfate into glomerular
macromolecules of ex situ
perfused normal (9) and
xyloside (*) treated kid-
neys . Each point repre-
sents labeled macromole-
cules in glomeruli isolated
from a single perfused kid-
ney . All the experiments
were performed with a sin-
gle batch of [' SS]sulfate
2
￿
s
￿
4
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and within 2-3 d to elimi-
nate any variability due to
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Control Xyloside
Glomeruli
Total -0 .85 x 10 6 dpm -0.20 x 106 dpm
Peak 1 100% ^-40%
Peak 2 - -60%
Media
Total -8.56 x 106 dpm 16.88 x 106 dpm
Peak A -30% -15%
Peak B ^-70% -85%a
O
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FIGURE 3
￿
Sepharose CL-6B chromatograms of aliquots of glomer-
ular extracts from normal (A) and xyloside-treated (B) kidneys;
untreated (-) and after treatment with chondroitinase-ABC
(- - -) or nitrous acid (---).
mately 40 and 60% of the radioactivity was associated with
peaks 1 and 2, respectively. After treatment with chondroitin-
ase-ABC, -10 and -30% of the radioactivity from peaks 1
and 2 was released into the V, fractions (Fig. 3 B). With nitrous
acid oxidation, -90 and -70% of the radioactivity was re-
leased into the V, fraction (Fig. 3B). The results of these
treatments suggest that peak 2 contains relatively more of the
chondroitinase-ABC sensitive proteoglycan than does peak 1 .
Characterization of GAG Chains of Extracted
Glomerular Proteoglycans
20 4 40
￿
60 4 80
Vo
￿
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FRACTION
The GAG chains of glomerular Proteoglycans obtained
from control kidney eluted as a single peak of radioactivity
with a K, value of 0.47; M, = 25,000 (45). Treatment with
nitrous acid or chondroitinase-ABC resulted in the release of
-95 or -5% of the radioactivity, respectively, into the V,
fractions (Fig. 4A). No significant change in the elution
profiles of the resistant GAG peakswas observed.
The GAG chains of glomerular Proteoglycans obtained
from xyloside-treated kidney eluted as a single peak of radio-
activity with Kv value of0.47, Mr = 25,000 (45). Treatment
with nitrous acid or chondroitinase-ABC resulted in the re-
lease of -65 or -35%, respectively, of the radioactivity into
the V, fractions (Fig. 4B). Successive treatments ofchondroi-
tinase-ABC and nitrous acid released all the counts into the
V, fraction, indicating that the xyloside treatment did not
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FIGURE 4 Sepharose CL-6B chromatograms of GAG chains from
glomeruli of control (A) and xyloside-treated (B) kidneys; intact
chains (-) and after treatment with chondroitinase-ABC (- - -)
or nitrous acid (---).
result in the de novo synthesis ofa new class of Proteoglycans
or GAGS.
In addition, the GAG chains, obtained from elution peaks
1 (fractions 35-45) and 2 (fractions 46-56) ofSepharose CL-
6B chromatograms (Fig. 3 B) of Proteoglycans extracted from
xyloside-treated kidneys, were characterized. Aliquots of each
peak were treated with 0.5 N NaOH to release GAG chains.
The treated samples were then dialyzed, lyophilized, and
chromatographed before and after treatment with chondroi-
tinase-ABC or nitrous acid. Chondroitinase-ABC and nitrous
acid treatments released -10 and -90%, respectively, of the
radioactivity into the V, fractions from the GAG chains (K
= 0.47, M, = 25,000) obtained from peak 1 (Fig. 5A).
Similar treatments ofGAG chains (Ka,, = 0.47, M, = 25,000)
from peak 2 released -45 and -55% of the radioactivity into
the V, fraction (Fig. 5 B).
The data so far obtained from characterization of glomer-
ular proteoglycan and GAGS indicate that with xyloside treat-
ment, there is an overall decreased synthesis of proteoglycan
and a relative increase in the synthesis of chondroitin sulfate
compared with heparan sulfate. The increase in the synthesis
of chondroitin sulfate varied from 30-40%, as determined
from various elution profiles from different experiments.
Behavior of Glomerular Proteoglycans and GAGs
When the extracted glomerularProteoglycans from control
kidneys were fractionated in a dissociative CsCI density gra-20
Ke =0.47
1
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￿
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￿
4 6o
v° FRACTION
￿
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5 Sepharose CL-6B chromatograms of alkaline-treated FicuRE
fractions corresponding to peak 1 (A) and peak 2 (B) of Fig. 3B.
Profiles for intact chains (-) and for samples treated with chon-
droitinase-ABC (- - -) or nitrous acid (---) are shown.
dient, a reasonable separation of the two types of proteogly-
cans was achieved. Nitrous acid-sensitive proteoglycan, i.e.,
heparan sulfate-proteoglycan (HS-PG) was exclusively present
in the denser D, and D2 fractions ofthe gradient, with the D,
fraction containing -70% of the total radioactivity of the
gradient (Fig. 6A, left-hand bar graph). The chondroitin sul-
fate proteoglycan (CS-PG) was present in small amounts along
with HS-PG in the lighter D4 and DS fractions ofthe gradient.
Aliquots of the D,-DS fractions of the CsCl gradient each
eluted as a single peak on Sepharose CL-6B chromatography,
and no significant change in the K values (-0.25) was
observed (figure not shown).
When glomerular proteoglycans from xyloside-treated kid-
neys were fractionated in the dissociative CsCl density gra-
dient, only a partial separation of the two types of proteogly-
cans could be achieved (Fig. 6A, right-hand bar graph). Al-
most 95% of the D, fraction was nitrous acid sensitive, and
the proteoglycan in this fraction eluted as a single peak with
Ka, value -0.25, indicating that the proteoglycans in peak 1,
Fig. 3B, are very similar to those in the control. Except for
the D, fraction of the gradient, the other fractions eluted as
two peaks (Ka,, = -0.25 and -0.41) similar to those shown in
Fig. 3B. The decrease in the buoyant density of the CsCl
gradient fractions (D2-DS) corresponded to an increase in the
presence of chondroitinase-ABC-sensitive material, with the
Ds fraction containing almost equal proportions of CS and
HS. In addition, in the lighter D4 and DS fractions, relatively
more CS was consistently present in the second peak of the
Sepharose CL-6B chromatograms than in the first, similar to
the results shown in Fig. 3 B. Therefore, the proteoglycans in
peak 2, Fig. 3B, have lower average buoyant densities than
peak 1 proteoglycans.
The sedimentation behavior of released GAG chains was
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FIGURE 6
￿
Sedimentation behavior of glomerular proteoglycans (A)
and GAGS (B) of control (left-hand bar graphs in A and B) and
xyloside-treated (right-hand bar graphs in A and B) kidneys in CsCl
gradient. In controls, the HS-PG sedimented in the denser D, and
Dz fractions (A, left-hand bar graph) whereas in xyloside-treated
kidneys, HS-PG as well as CS-PG were distributed throughout the
gradient fractions (A, right-hand bar graph). The GAG chains, in
control (B, left-hand bar graph) sedimented in the D, fraction (-65%
of the total radioactivity) and contained exclusively heparan sulfate.
The GAG chains from xyloside-treated glomeruli also sedimented
mainly in the D, fraction (-60% of the total radioactivity); however,
it contained both the chondroitin sulfate (-35%) and heparan
sulfate (-65%). ND, not determined.
also determined in dissociative CsCI gradients. The GAG
chains from control (Fig. 6B, left-hand bar graph) and xylo-
side-treated samples (Fig. 6B, right-hand bar graph) sedi-
mented mainly in the D, fractions which contained -65 and
-60% ofthe total radioactivity, respectively. The D, fractions
were chromatographed on Sepharose CL-6B before and after
treatment with chondroitinase-ABC or nitrous acid. The D,
fraction of the GAG chains from glomerularproteoglycans of
normal kidney contained almost exclusively heparan sulfate,
while the D, fraction of the GAG chains from glomerular
proteoglycans of xyloside-treated kidney contained -35 and
-65% of chondroitin and heparan sulfates, respectively. The
other fractions, D2-D5, were not analyzed further. The fact
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the intact molecules further indicates that the peak 2 (Fig.
3 B) molecules are proteoglycans and not free GAG chains.
Characterization of Medium Proteoglycan
and GAGS
Aliquots of labeling medium were eluted on Sephadex G-
50, and the excluded fractions were collected, pooled, and
lyophilized. They were then dissolved and applied to a DEAE-
Sephacel column eluted with a 0.1-1.0 M NaCl continous
gradient. In the medium of control kidneys, the incorporated
['SS]sulfate eluted as a single sharp peak of radioactivity at
-0.25 M NaCl (Fig. 7A). With the medium from xyloside-
treated kidneys, the incorporated ['SS]sulfate eluted as a some-
what broader peak but at the same salt concentration (Fig.
7B). The total incorporated 'SS activity in the whole-medium
fractions (total volume 80 ml) ofthe control and of xyloside-
treated kidneys was -8.6 x 106 and -16.9 x 106 dpm,
respectively (Table I). These data indicated that there were
substantial amounts of de novo synthesized proteoglycans
and GAGs which were discharged into the perfusion medium
compartment for both samples. Furthermore, with the xylo-
side treatment, about twice as many de novo synthesized
molecules were released into the medium.
The characterization of medium proteoglycan and GAGs
was carried out by Sepharose CL-6B chromatography. The
medium proteoglycan and GAGs from control kidneys eluted
as two peaks of radioactivity, A and B, with corresponding
Kav values of -0.25 and -0.47, respectively (Fig. 8A). This
indicated that medium contains both the macromolecular
form ofproteoglycan (Ka, = -0.25) and free GAG chains (Ke,
= -0.47). The incorporated 'SS activity was relatively more
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FIGURE 7 Elution profiles of incorporated ['SS]sulfate of media
from control (A) and xyloside (B) experiments on DEAE-Sephacel .
The samples applied to DEAE-Sephacel were obtained from void
fractions from Sephadex G-50 chromatography.
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FIGURE 8
￿
Sepharose CL-6B chromatograms of media fractions ob-
tained after DEAE-Sephacel chromatography from control (A) and
xyloside (B) experiments. In control, two peaks, A and B (-), are
observed. With chondroitinase ABC (---) or nitrous acid (- .-)
treatments, -10% or -90%, respectively, of the radioactivity was
released into the V, fractions. In xyloside experiments, again two
peaks (-) are observed, with most of the radioactivity associated
with peak B. The treatments with chondroitinase-ABC (- - -) and
nitrous acid (---) indicate that peak B had almost equal proportions
of heparan and chondroitin sulfate.
associated with free GAG chains in the medium. Treatment
with nitrous acid or chondroitinase-ABC indicated that -90%
ofthe radioactivity in the medium was associated with hepa-
ran GAGs (Fig. 8A).
The incorporated 'SS activity in the medium of xyloside-
treated kidneys also eluted as two peaks with K_ values
corresponding to a macromolecular form ofproteoglycan (Ka
= -0.25, peak A) and free GAG chains (K., = -0.47, peak
B) (Fig. 8B). Most of the radioactivity was associated with
peak B indicating the predominant presence of GAG chains.
The data indicate that with xyloside treatment, a larger frac-
tion oflabeled free GAG chains was released into the medium.
The results of the treatment with chondroitinase-ABC and
nitrous acid indicated that peak A contained mostly the HS-
PG, while peak B was enriched with chondroitin sulfate,
-60% of the total (Fig. 8B). These data on the characteriza-
tion of medium proteoglycan/GAG suggest that with xyloside
treatment, there is a twofold increase in the de novo synthesis
of free GAG chains, predominantly composed of chondroitin
sulfate.
The organ perfusion system employed in this investigation
provided an effective means of determining the effect of ß-D-xyloside on the de novo synthesized glomerularproteoglycans.
The results obtained establish that xyloside competes with the
native acceptor for the initiation of synthesis of heparan and
chondroitin sulfate chains. The net synthesis of glomerular
proteoglycan was markedly reduced in the presence of xylo-
side. The effect of xyloside did not seem to be due to its
cytotoxicity since no discernible changes in the morphology
of the glomerular cells were observed during the time frame
of the labeling period. The Golgi complexes appeared normal
up to the concentration of 2.5 mM of xyloside in the perfusion
medium . The glomerular matrices also remained unaltered.
Thus, in the absence of recognizable morphological changes
in the glomerulus, the decreased 15S incorporation in the
matrices appears to be due to the reduced addition of GAG
chains onto the core protein rather than to the toxicity of
xyloside. This phenomenon has also been observed in other
culture systems as well, where the effect of xyloside has been
investigated (7, 22, 25, 26, 29, 32, 36-40, 42-44).
Previously, the effects of xyloside have been studied most
extensively in systems that synthesize cartilage-specific (i.e.,
chondroitin sulfate) proteoglycans (25, 26, 29, 36, 37). In such
systems, xylosides have been demonstrated to compete with
the core protein for initiation ofchondroitin sulfate synthesis.
The data presented here indicate that the xyloside can also
influence the synthesis of HS-PG on the core protein of HS-
PG of extracellular matrices. The effect of xyloside on the
synthesis of core protein of glomerular proteoglycans is ex-
tremely difficult to assess because of the technical limitation
of labeling the peptide chain in the perfusion system. How-
ever, in view of the results obtained in past experiments with
embryonic chick chondrocytes (36) and chick limb bud mes-
enchymal cells (25), the core protein synthesis may not be
affected by the xyloside treatment. Consequently, the inhibi-
tion of HS-PG synthesis in the presence of ß-xyloside results
from competition of xyloside with the acceptor of heparan
sulfate on the core protein for initiation of heparan sulfate
synthesis rather than any change in core protein synthesis
itself.
The proteoglycans synthesized in the presence of xyloside
were of two types as indicated by two elution peaks (peaks 1
and 2) on Sepharose CL-6B chromatograms. The larger mo-
lecular weight proteoglycan (peak 1, Fig. 3B) contained
mostly (-90%) heparan sulfate GAG chains while the smaller
molecular weight proteoglycan (peak 2, Fig. 3B) contained a
mixture of heparan sulfate (-70%) and chondroitin sulfate
(-30%) GAGS. The presence of larger amounts of de novo
synthesized chondroitin (or dermatan) sulfate in the smaller
molecular weight proteoglycan indicates that xyloside must
have some stimulatory effect on the net synthesis of chon-
droitin sulfate including synthesis on core proteins. This
stimulatory effect is further substantiated by the fact that a
three- to fourfold increase in incorporated "S activity associ-
ated with chondroitin sulfate GAG chains, presumably syn-
thesized on xyloside primer, was observed in the perfusion
medium. Similar effects have also been observed in other
culture systems (7, 22, 25, 26, 29, 32, 36-40, 42-44), but
whether such effects are indeed operative under in vivo con-
ditions is unknown. The xyloside perturbed synthesis ofGEM
proteoglycans was also reflected in some of their physico-
chemical properties. In controls in a CsCl gradient, the HS-
PG was concentrated in the denser bottom D, fraction. How-
ever, the peak 2 HS-PG and CS-PG synthesized under the
influence of xyloside, distributed throughout the gradient in
NORMAL, HS-PG
￿
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K_, 0.25
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Kav-0.41
FIGURE 9
￿
Schematic drawing of the glomerular HS-PG before and
after treatment with xyloside.
variable proportions. This is probably reflective of the change
in the buoyant density of the proteoglycans which is directly
related to fewer chains present on the core protein. A sche-
matic drawing of the presumptive change that occurs under
the influence of xyloside is given in Fig. 9 and is derived in a
manner similar to the results obtained by Lohmander et al.
(25) on the CS-PG in chick limb bud mesenchymal cell
experiments. The fact that under the influence of xyloside
two types of proteoglycans are synthesized, i.e., a larger one
(peak 1, Fig. 3B) that behaves like normal HS-PG and a
smaller one (peak 2, Fig. 3B) with fewer GAG chains, and
that both species of proteoglycans contain the same size
GAGS, indicate that this is a direct consequence of xyloside
competition with the endogenous core for both heparan and
chondroitin (or dermatan) sulfate synthesis. The free GAG
chains (including xyl-GAG) would concentrate in the D,
fraction (Fig. 6B) and are absent in the glomerularextract of
xyloside-treated kidneys indicate that they are retained on the
core protein of the proteoglycans and that the core protein is
essential for theirretention in the GEMS. The net decrease in
incorporated activity for xyloside-treated kidneys is then pri-
marily the result of decreased numbers of chains on the core
as represented by peak 2 (Fig. 3B). Why the proportion of
chondroitin (or dermatan) to heparan sulfate increases under
the influence of xyloside is not known.
The fact that the ß-D-xyloside can selectively perturb the
synthesis of HS-PG may allow one to further explore certain
aspects of the mechanisms by which HS-PG determines the
permselectivity properties of the GBM in in vivo states. The
HS-PG of the GBM has been shown to regulate the transglo-
merular passage of macromolecules like ferritin (15) and
albumin (34). In addition, HS-PG has been implicated in the
protection of the GBM from "clogging" by the circulating
plasma proteins by virtue ofits high degree ofelectronegativity
and hydrophilicity (16). These observations concerningperm-
selectivity and clogging have been made from experiments
carried out under in situ perfusion conditions in which certain
determinants ofpermeability, e.g., renal bloodflow and trans-
capillary hydraulic pressure difference, are not accurately
maintained. Therefore, with the knowledge that ß-D-xyloside
inhibits the synthesis of HS-PG of GBM, it is plausible that
the experiments can be reproducedin in vivo states where the
hemodynamic conditions ofthe glomerulusare well regulated.
Furthermore, it is conceivable that long-term in vivo treat-
ment with /3-D-xyloside may give some insights into the
influence of HS-PG on the process of assemblage ofbasement
membranes. To this end, interestingly enough, an associated
loss of HS-PG with thickening of GBM in experimentally
KANWAR ET AL.
￿
Effect of,#-o-Xyloside on Glomerular Proteoglycans
￿
72 1induced diabetic nephropathy (18) and lamination and split-
ting of tubular basement membranes in drug-induced renal
polycystic disease (9) have been observed.
Finally, the present experiments do not shed any light on
the effect of xyloside on the inhibition/stimulation of a par-
ticular cell type/types of the glomerulus. To obtain such
information, one has first to determine the normal cellular
biosynthesis of GEMS, which at present is unknown. The
glomerulus is made up of three cell types (i.e., epithelium,
endothelium, and mesangial cell), and it is presumed by most
workers in this field that perhaps all the cells participate in
the synthesis of proteoglycans of GEMS (8). The data from
glomerular cell culture lines indicate that the mesangial cells
synthesize CS-PG to a large extent while epithelial and en-
dothelial cells predominantly synthesize HS-PG (41). It is
conceivable that the xyloside could selectively stimulate the
mesangial cell (mesenchymal in origin) for increased synthesis
of chondroitin sulfate. However, whether this actually occurs
under in vivo conditions remains to be determined. Quanti-
tative electron microscopic autorádiographic studies are in
progress to answer these questions about the effect of xyloside
on cellular biosynthesis.
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